ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Stomach Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Breast Cancer

Pancreatic Cancer trials near San Antonio, TX, USA:

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

in combination with chemotherapy as the first-line treatment for subjects with CLDN18.2-positive locally advanced unresectable or metastatic pancreatic...

Enrolling
Pancreatic Cancer
Drug: mFOLFIRINOX [Oxaliplatin+irinotecan+leucovorin+fluorouracil]
Drug: ANO31905

Phase 1, Phase 2

Anova Innovation Limited

San Antonio, Texas, United States and 2 other locations

study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
G12D Mutated KRAS
Drug: VS-7375
Drug: cetuximab (or panitumumab if α-gal IgE+ or cetuximab reaction)

Phase 2

Verastem

San Antonio, Texas, United States and 37 other locations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...

Enrolling
Metastatic Pancreatic Carcinoma
Stage IV Pancreatic Cancer AJCC v8
Drug: Pemigatinib
Procedure: Bone Scan

Phase 2

Sameek Roychowdhury

San Antonio, Texas, United States and 108 other locations

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, ...

Enrolling
Pancreatic Adenocarcinoma
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Drug: ASP546C

Phase 1, Phase 2

Astellas
Astellas

San Antonio, Texas, United States and 21 other locations

(an anti-PD-1 antibody) in combination with SX-682 (a CXCR1/2 inhibitor) in subjects with newly diagnosed and surgically resectable pancreatic...

Enrolling
Pancreatic Cancer
Drug: Tislelizumab
Drug: SX-682

Phase 2

Lei Zheng

San Antonio, Texas, United States and 1 other location

The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Adenocarcinoma Metastatic
Drug: mGnP
Drug: GnP

Phase 3

Immuneering Corporation

San Antonio, Texas, United States and 71 other locations

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of RMC-5127 as a monothe...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: cetuximab
Drug: daraxonrasib

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 8 other locations

Locations recently updated

medicine (called PF-08098488) in people with advanced solid tumors (cancer that cannot be removed with surgery or has spread to other parts ...

Enrolling
Esophageal Cancer
Pancreatic Ductal Adenocarcinoma
Drug: PF-08098488

Phase 1

Pfizer
Pfizer

San Antonio, Texas, United States and 3 other locations

The purpose of this study is to evaluate the safety, tolerability, and efficacy of BMS-986523 alone and in combination with anti-cancer agen...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: Pembrolizumab
Drug: Cetuximab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

San Antonio, Texas, United States and 7 other locations

This study is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant sol...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems